Navigation Links
Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune

CARLSBAD, Calif., April 23, 2007 /PRNewswire-FirstCall/ Micromet, Inc. today announced the achievement of a milestone in its research collaboration with MedImmune, Inc. for the development of new BiTE(R) molecules targeting carcinoembryonal antigen (CEA), a validated tumor- associated antigen frequently expressed on various human carcinomas. Preclinical data recently presented at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) showed that CEA-BiTE molecules can prevent subcutaneous tumor growth and formation of lung metastases. Achievement of the preclinical proof-of-concept milestone in the CEA-BiTE program triggers an undisclosed payment from MedImmune to Micromet.

Micromet holds exclusive European rights to the CEA-BiTE program and is eligible for milestones and royalties for all other territories, including the U.S. Under the same agreement, both companies also collaborate on a new BiTE candidate targeting the tyrosine kinase receptor EphA2, which is frequently overexpressed on a wide variety of solid tumors.

"The achievement of this milestone further validates the versatility and power of the BiTE approach to treat various cancers by targeting different tumor antigens," said Patrick Baeuerle, Ph.D., Chief Scientific Officer of Micromet. "Following this initial success with the CEA-BiTE program, we are now advancing the second BiTE program through formal development with our partner MedImmune."

About BiTE(R) Molecules:

BiTE(R) molecules are a novel class of antibody derivatives with the potential to selectively direct and activate an individual's cytotoxic T cells, the body's most potent killer cells, to act against cancer cells. MT103/MEDI-538, a BiTE molecule targeting the B cell antigen CD19, provided clinical proof-of-concept for the BiTE platform technology, as presented at the most recent meeting of the American Society for Hematology. In an o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
4. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
5. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
8. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
9. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
10. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
11. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
Post Your Comments:
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
(Date:5/23/2013)... N.M. , May 23, 2013  Net Medical ... the telemedicine market, announced today the company has signed ... telemedicine staffing company based in Huntsville, AL ... that specializes in the staffing and recruitment of telemedicine ... completion of the final agreement, which is expected by ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing 2Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing 3Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 2Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 3Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 4Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 5Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 6Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 7Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 8Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 9Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 10Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 11Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 12Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 13Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 14Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 15Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 16Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 17Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 18
(Date:5/25/2013)... 25, 2013 HealthCrave Medical Centers ... unique in that it doesn’t just focus on ... treating what causes the noticeable signs of aging ... James D. Weiss, M.D., the center provides safe ... while helping patients to live longer, healthier lives. ...
(Date:5/24/2013)... FL (PRWEB) May 25, 2013 The ... Cellulite Whisperer ® products from Sublime Beauty®. The ... to diminish cellulite, and many of the ingredients are ... deal with and is dreaded by many women," says ... concentrated holistic plan, women can diminish their cellulite." The ...
(Date:5/24/2013)... May 25, 2013 myMEDholiday.com, a popular ... healthcare providers in five important medical travel destinations in ... Patient Guide to ensure a safe and successful ... This 15-step manual offers tips on cost-savings, how to ... your itinerary, and a wealth other essential advice. , ...
(Date:5/24/2013)... 2013 Today, Zane Benefits, Inc. ... Health Insurance Exchange . Zane Benefits, which provides ... health benefits, is the leader in defined ... . , According to Zane Benefits’ website, beginning ... Act (ACA), health insurance coverage for individuals and ...
(Date:5/24/2013)... , , FRIDAY, May 24 (HealthDay News) -- As a ... was a physical challenge in her childhood that defined ... "I was an 11-year-old girl with my heart set ... my orthopedic surgeon," said Lewis, who has become a ... American Academy of Orthopaedic Surgeons so she can help ...
Breaking Medicine News(10 mins):Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:myMEDholiday.com Introduces International Patient Guide to Assist People Planning Treatment Abroad 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3
... Feb. 6 Baycap Inc. ("Baycap"),today announced that it ... School. Todd Coordt and Peter Metropoulos, directors at Baycap,are ... commented:,"This provides the school with top of the line ... The equipment will allow Mira Costa to add ...
... Union asks board member to seek restatement of Beth ... Staples director Martin Trust,should apply the same Sarbanes-Oxley standards ... role on the board of Beth Israel Deaconess,Medical Center ... East. Trust is the CEO of Samtex and a ...
... America,s favorite doctor,Mehmet Oz, M.D., recently revealed ... Winfrey Show with blueberries topping the list as ... one of his,"favorite" anti-aging superfoods. "You can tell ... color. All foods with dark colors in,them have ...
... Mangrove Employer Services, a,leading software and services ... and Self Service solutions,announces the launch of its ... Services teamed up with an experienced and trusted,partner, ... services, in 2007 to provide this new offering. ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... the same Sarbanes-Oxley standards used by Staples and other,publicly ... Beth Israel Deaconess,Medical Center (BIDMC), according to labor group ... directors should,take similar action, says a letter sent today ...
... Feb. 6 HLTH,Corporation (Nasdaq: HLTH ) and ... ), today announced that they will release their respective,financial ... at,approximately 4:00 pm (ET) on Thursday, February 21, 2008. ... (ET) on that day to discuss those,results., Investors ...
Cached Medicine News:Health News:Staples Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Dr. Oz and Oprah Pick Antioxidant-Rich Blueberries for Ultimate Checklist for Great Aging 2Health News:Mangrove Announces Health Savings Account (HSA) and Health Reimbursement Account (HRA) Product Launches 2Health News:Board Members of Five Massachusetts Companies Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call 2
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... Graham-Field has been developing ... than 58 years. Our medical-surgical ... reputation for innovation, quality and ... brands include the Labtron® line ...
... of medication as well as humidification, try ... dilution, high volume, continuous medication nebulizer (CMN), ... patients. Its 200 ml reservoir and jet ... hours of nebulized medication delivery at 25 ...
Rotary Piston Nebulizer...
Medicine Products: